NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice-Reference-Cited by-同舟云学术

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice

Published:2017-11-11 Issue:11 Volume:22 Page:1950
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Kaloudi Aikaterini,Lymperis Emmanouil,Giarika Athina,Dalm Simone,Orlandi Francesca,Barbato Donato,Tedesco Mattia,Maina Theodosia,de Jong Marion,Nock Berthold

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/22/11/1950/pdf

Reference44 articles.

1. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

2. Radiopharmaceutical development of radiolabelled peptides

3. Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer

4. Radiopeptides for Imaging and Therapy: A Radiant Future

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review;Seminars in Nuclear Medicine;2024-03

2. Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers;Cancer Imaging;2024-01-26

3. Theranostic Radiopeptides in Nuclear Oncology: Design, Preclinical Screening, and Clinical Translation;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

4. GRPR-targeting radiotheranostics for breast cancer management;Frontiers in Medicine;2023-11-03

5. The Balance Between the Therapeutic Efficacy and Safety of [177Lu]Lu-NeoB in a Preclinical Prostate Cancer Model;Molecular Imaging and Biology;2023-08-28